Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia - The New England Journal of Medicine - 1995
Brief Summary:
Among men with hyperlipidemia, pravastatin reduced the composite endpoint of nonfatal MI or death from CAD at 5 years.Reference: http://www.ncbi.nlm.nih.gov/pubmed/7566020
Comments
Post a Comment
Drop your thoughts here, we would love to hear from you